Abstract Holoprosencephaly (HPE) is the most common birth defect of the brain in humans. It involves various degrees of incomplete separation of the cerebrum into distinct left and right halves, and it is frequently accompanied by craniofacial anomalies. The HPE1 locus in human chromosome 21q22.3 is one of a dozen putative genetic loci implicated in causing HPE. Here, we report the complete gene structure of the human lanosterol synthase (LS) gene, which is located in this interval, and present its mutational analysis in HPE patients. We considered LS an excellent candidate HPE gene because of the requirement for cholesterol modification of the Sonic Hedgehog protein for the correct patterning activity of this HPE-associated protein. Despite extensive pedigree analysis of numerous polymorphisms, as well as complementation studies in yeast on one of the missense mutations, we find no evidence that the LS gene is in fact HPE1, implicating another gene located in this chromosomal region in HPE pathogenesis.
Introduction
Holoprosencephaly (HPE) is a clinically heterogeneous brain malformation, which can be caused by genetic and/ or environmental factors (Ming et al. 1998a; Roessler and Muenke 1998) . In cyclopia, the most severe form, there is a single eye, a superiorly placed nasal structure called a proboscis, and the lack of separation of the cerebral hemispheres into discrete left and right halves (Cohen 1989) . The clinical HPE spectrum is variable even in autosomal dominant families segregating mutations in a single HPE gene such as Sonic Hedgehog (Ming and Muenke 1998) . Craniofacial findings of microcephaly, hypotelorism, or a single central incisor can be clinical clues to underlying brain anomalies comprising HPE (DeMyer et al. 1964) . Recently, several genes have been identified with a role in HPE pathogenesis, including Sonic Hedgehog (HPE3) Roessler et al. 1996 Roessler et al. , 1997a Roessler et al. , 1997b , the transcription factor ZIC2 (Brown et al. 1998a (Brown et al. , 1998b , SIX3 (HPE2) (Wallis et al. 1999) , and several others currently under investigation (Gripp et al. 1998; Ming et al. 1998b ). The HPE1 locus on human chromosome 21q22.3 is one of several named HPE loci (Frézal and Schinzel 1991) and is defined by a set of three overlapping cytogenetic deletions (Muenke et al. 1995) .
The lanosterol synthase (LS) enzyme catalyzes the cyclization step in the biosynthesis of cholesterol. Among the essential functions of cholesterol in preserving the integrity of cell membranes and, as the substrate for the synthesis of sterols and hormones, there is a novel role recently described for cholesterol as an adduct to signaling molecules such as Sonic hedgehog (Porter et al. 1996a (Porter et al. , 1996b . Undermodification of the Sonic Hedgehog protein is suspected to be a contributing factor in the pathogenesis of Smith-Lemli-Opitz (SLO) syndrome, which in turn is associated with an increased incidence of HPE (Kelley et al. 1996) . SLO has been shown to result from the biochemical deficiency of cholesterol during fetal development (Cunnif et al. 1997) and is associated with mutations in the enzyme that catalyzes the penultimate step in cholesterol biosynthesis, 7-delta sterol reductase Moebius et al. 1998; Wassif et al. 1998; Waterham et al. 1998) . We speculated that mutations in the human LS gene might lead to similar patterning deficiencies of the Sonic Hedgehog protein and contribute to brain malformations within the HPE spectrum. Now, we report on the gene structure of the human LS gene and a strategy to amplify each coding exon for mutational analysis. Here, we show the mutational analysis of the human LS gene (Young et al. 1996) , which maps within the 5 cM minimal critical region for HPE1 (Muenke et al. 1995) .
Materials and methods

Determination of the LS gene structure
Having previously identified a cosmid 7G8 (Young et al. 1996) that contained the 5' end of the LS gene, we used the primer pairs LSH2830F (5' ggcaggtagtgtgcatccgt 3') and HSLS3000R (5' gacttgggatgttccatgacagac 3'), derived from the 3' UTR sequence, as a probe to screen a chromosome-21-specific cosmid library (LL2INCO2-Q, Soeda et al. 1995) for the 3' end of the gene. A single cosmid, 72H3, was chosen for further analysis, since it completed the contig for the entire LS gene. Putative exon-specific primers based on the cDNA sequence and the initial 5 trapped exons (Young et al. 1996) were then used to sequence the cosmids and to determine the first set of intron/exon boundaries. Additional primers were then synthesized to determine the sequence of both DNA strands adjacent to the intron/exon boundaries as each new set was empirically determined. Note that the initiator methionine is in exon 2. Genbank numbers are as follows: accession no. AJ239021 (exons 2, 3, and 4), AJ239022 (exons 5 and 6), AJ23903 (exon 7), AJ239024 (exons 8, 9, and 10), AJ239025 (exon 11), AJ239026 (exon 12), AJ239027 (exons 13 and 14), AJ239028 (exons 15, 16, 17, and 18), AJ239029 (exons 19 and 20), AJ239030 (exon 21), AJ239031 (exons 22 and 23). Sequencing was performed on an ABI PRISM 377 automated sequencer.
Patients and DNA preparation Patient samples were obtained after being given informed consent according to the guidelines of the Children's Hospital of Philadelphia Institutional Review Board, and DNA samples were prepared from blood or lymphoblastoid cells lines using routine methods. Three HPE patients had various deletions, including the distal long arm of chromosome 21. Two of these were previously published: 46,XX,del(21)(q22.3->qter) and 46,XY,-21,+der(21)t(10;21) (p11.2;q22.3)mat (Muenke et al. 1995) . A third patient with semilobar HPE had the following karyotype: 46,XY,r(21).
A total of 30 HPE patients from 20 unrelated families were chosen for single-strand conformational polymorphism (SSCP) analysis. These HPE families were chosen for their apparent autosomal recessive pedigrees with clinically normal parents and multiple affected children. These families included the typical range of HPE phenotypes. When SSCP band shifts were detected, these samples were sequenced to determine the potential mutations. Where possible, the sequence variations were examined in the parents and siblings to determine the pattern of transmission and also examined in a panel of normal controls to determine any correlation with the disease state or uniqueness of the sequence variations. All families were too small for effective linkage analysis. As has been shown, some of these families could also be consistent with germline mosaicism for a dominant HPE gene, such as SHH (Roessler et al. , 1997a or SIX3 (Wallis et al. 1999 ).
Reverse-transcriptase polymerase chain reaction analysis Poly-A selected RNA was isolated from lymphoblastoid cell lines (FastTrack, InVitrogen), synthesized into complementary DNA using random primers (cDNA cycle kit, InVitrogen), and amplified with the three primer sets as depicted in Fig. 1 . The first primer pair is LSF2 (5' cccaagcttagggggctctgaacgggatgaca 3') and LSR2 (5' cccaagcttcgatgctgatgctcttggtgaat 3'), which overlaps with the second primer pair LSF3 (5' ggggaattcccgacgaccgattcaccaa 3') and LSR3 (5' cccaagcttaggagcagcacagccttcaa 3'), which overlaps with the last amplicon LSF4 (5' ggggaattccccagataaccctcccgactacc 3') and LSR4 (5' cccaagcttttcctcacccaagcccgacaagc 3'). Amplicons were directionally subcloned into Bluescript KS -(Stratagene) using the HindIII or EcoRI sites nested within them and pools of at least 20 clones were subjected to automated sequencing. Candidate sequence changes were confirmed by individual exon amplification using patient genomic DNA and re-sequencing. The reversetranscription polymerase chain reaction (RT-PCR) products were sufficient to screen exons 5 to 23; the first three coding exons (2, 3 and 4) were analyzed by direct amplification and sequencing of the patient genomic DNA.
Mutational analysis
Amplification of genomic DNA was performed in a 15-µl reaction volume, using 60-100 ng DNA template, 200 µM each of dATP, dGTP, and dTTP, 125 µM dCTP, 3.5 µCi α 32 P-dCTP (800 Ci/mmol [10 mCi/ml]), 30 pmol each primer, 1.5 µl 10× PCR buffer (Gibco), 1.25 µl 10× PCR Enhancer (Gibco), 1.5 mM MgSO 4 (Gibco), and 1 U Amplitaq polymerase (Perkin Elmer). All of the PCR reactions were performed in a PTC-100 thermal cycler (MJ Research, Inc.) .
For SSCP analysis, following amplification, 5 µl of each sample was diluted with 10 µl stop solution [9.5 ml deionized formamide (Fluka), 20 mM ethylene diamine tetraacetic acid (EDTA), 0.5% (w/v) bromophenol blue, and 0.5% (w/v) xylene cyanol], denatured for 10 min at 94°C, then immediately chilled on ice. The samples were run either with or without 5% glycerol at room temperature on 0.5× MDE gel solution (FMC Bioproducts) sequencing-grade polyacrylamide gels. Sequencing of the amplicons demonstrating SSCP band shifts was performed by the Protein and DNA Core Facility of the Children's Hospital of Philadelphia on an ABI Prism 377 analyzer.
Functional analysis of LS activity
The yeast LS cDNA (Corey et al. 1994 ) was modified by site-directed mutagenesis (Ausubel et al. 1999 ) to include the corresponding K625Q mutation and was expressed in a yeast mutant for functional complementation analysis. The yeast LS mutant SMY8 was transformed using this construct, and the resultant strain's ability to grow on media without supplemental ergosterol was tested as described previously (Corey et al. 1996) .
Results
Structure of the human LS gene
A contig of two cosmids (7G8 and 72H3) was analyzed to identify 23 individual exons spanning 40-50 kb of genomic DNA for the LS gene as diagramed in Fig. 1 . The genomic structure shown in Fig. 1 , predicts a total of 22 coding exons and is in agreement with the cDNA sequence (Baker et al. 1995) . Note that the 5' untranslated region represented as exon 1 has not been completely characterized. Also note that the sequence variants seen in the hemizygous probands (see below) were detected as expressed transcripts as well as from genomic DNA, indicating that this is a functional gene. The relevant sequences of the intron/exon boundaries of the LS gene are shown in Table 1. RT-PCR analysis of HPE patients with deletions of 21q22.3
Poly-A RNA was isolated from an affected member of each of the three different 21q22.3 hemizygous deletions (these unrelated families are denoted here as families A, B, and C), which served to define the HPE1 locus. In all three cases, the deletion includes the human LS gene based on the comparison of the somatic cell hybrid data defining HPE1 (Muenke et al. 1995 ) and the genetic position of the YACs and cosmids containing the LS gene (Young et al. 1996) . We reasoned that these would be the most likely HPE individuals to have a loss of function mutation in the remaining LS allele. As shown in Table 2 (number 6), we found a sequence variation 863C>G in family A, predicting no change in the coding sequence (P288P) and this change was also noted in four additional HPE families (G, H, M, P) as a common polymorphism that failed to segregate with the disease. This sequence variant was also readily detectable in either the heterozygous or homozygous state in the normal control population. In family A, we also noted a 1949T>C sequence variation in exon 20, predicting no change in the coding sequence (H650H). This variation was seen as a homozy- Fig. 1 In the top panel, a diagram of the lanosterol synthase (LS) cDNA is shown aligned with a set of three amplicons used in reverse-transcription polymerase chain reaction (RT-PCR) experiments to subclone the EcoRI (R1) and HindIII (HIII) fragments a, b, c, and d for sequencing. In the bottom panel, the same LS cDNA diagram and its relationship to the genomic structure of individual exons is shown. Note that the coding exons extend from exon 2 to 23 gous variant in clinically normal individuals in families F and K, although, it was not readily detected in the analysis of the normal group of patients either because the band shift was minor under these gel conditions or that it was indistinguishable from the other band shifts in exon 20. There were no other sequence changes noted in either the cDNA fragments or the genomic amplicons for exons 2, 3 or 4 in family A. Similarly, for family B, we identified only one missense mutation in exon 20, predicting a conservative L641V change, that was also seen in four additional pedigrees (E, F, K, P); this 1923T>G mutation segregated as a common polymorphism and not with the affected status in these families (data not shown). This mutation is also commonly seen in the control population.
In family C, we identified a potentially significant missense mutation (Table 2, number 14) in exon 20. This 1864G>A sequence variation was not observed initially in over 100 normal chromosomes and predicts the substitution of a Q for an R residue at a position conserved as the positively charged residues R or K in the family of LS genes. When we tested the ability of this mutation to complement the ability of a LS mutant yeast strain to grow on media lacking ergosterol, the mutant form of the yeast protein allowed the transformed strain to grow normally (data not shown). This demonstrates that the mutant enzyme retains catalytic function. Subsequent analysis of 53 additional normal control individuals revealed that this is a rare polymorphism, since it was eventually detected in two normal control individuals. gaggagtggcaagtgtgtgg  12  077F  cctctctgtcctgctgtctcttcc  13  200  56  078R  tagggcagggtggaggtgaggtgg  13  204F  tgtcctctgcttccacatttgc  14  120  58  205R  cgggacagggatggggctggctcc  14  079F  ctgtggggaggttctgagaactgg  15  259  61  080R  ggtatggacggggctgctgggacc  15  121F  gtgtgtgctcagcacatgggc  16  172  58  122R  cgcgcgagtgctggccgacc  16  081F  tgcttgttgtggctttgcctgag  17  216  56  082R  acactgaatggctgagaccctcc  17  145F  ttcactggaccaatctcgtgttcc  18  162  59  146R  acgcagtgtgtgagagcagaaacc  18  123F  ggtggaagggctgaggctctccc  19  167  58  124R  acagagcattgggttgagaacc  19  125F  tgtgatggtgtctcctgtctctgg  20  239  60  126R  acccaggctcagggacggtcc  20  147F  gggtgtgtttcagccttctcttcc  21  160  60  148R  cacgctggaggtcagtgctgg  21  127F  aggctcacccacaagccagccaagc  22  268  60  128R  acagcgggcacccagcaggtaggc  22 SSCP analysis
We examined the entire coding region of the LS gene by means of SSCP in a total of 30 additional patients from 20 unrelated families with apparent autosomal recessive inheritance of HPE and present the results in Table 2 . The primers used for the amplification are described in Table  3 . We identified a total of 17 different sequence variations, which we number sequentially for clarity. The majority of these sequence variations were also detected in the normal control population (1, 2, 3, 4, 6, 8, 9, 10, 11, 12, 14, and 15) . For the remainder, either the analysis of the pedigree transmission and/or the benign nature of the sequence change predicts no correlation with the HPE phenotype. Seven of these sequence variations (3, 4, 7, (9) (10) (11) (12) occur in non-coding intronic sequences. Only one of these intronic variants was not readily detected in the control population. This intronic variation, number 7, predicts the substitution of a T for C in the pyrimidine tract of the consensus splice acceptor. This change is likely to be functionally equivalent.
Of the ten remaining sequence variations, four are in the wobble position, and the codons are predicted not to alter the primary structure of the protein (1, 5, 6, 16) . Of the six remaining missense mutations, one of these (number 14) has been excluded as a likely cause for HPE by functional studies in yeast; note also that we eventually detected this variant when we screened 53 additional normal controls. The sequence variant 13, the W576R substitution, is observed in an asymptomatic parent (family R) in the homozygous state. The identical mutation fails to segregate with HPE in a second family, K, where it is detected in a clinically normal mother and not either of her children with HPE. Therefore, this missense mutation is unlikely to exhibit a significant effect. The mutation 17 predicts a P688L change, which is observed in a normal parent and not his child with HPE. Although we did not detect this variant in the control population, the lack of a correlation with HPE makes this missense mutation unlikely to be responsible for HPE in this family.
The remaining three missense mutations are part of an interesting haplotype consisting of at least seven different sequence variations (1, 2, 4, 8, 9, 12, and 15) , which are transmitted as a unit from parent to child in three different HPE families. All of these sequence variants are detectable as common variants in the normal control population. In one of these families, D, the haplotype is observed only in the phenotypically normal mother and not her son with HPE. This mother has mutations 1, 2, 8, and 9 by sequencing and the remaining changes seen in the other two families (E and F) were not detected using SSCP. Furthermore, in family E, the haplotype is present in only one of two affected sibs, suggesting that these changes are irrelevant to the HPE phenotype, despite the fact that this haplotype accounts for the final three missense mutations.
Discussion
The Sonic Hedgehog gene was the first of several HPE genes to be identified, and there is growing evidence for many additional genes (Roessler and Muenke 1998) . We considered the LS gene as an excellent candidate since it was located within the HPE1 minimal critical region in 21q22.3, and cholesterol is an essential adduct to the carboxy-terminus of the signaling domain of SHH-N. This modification serves to limit the diffusion of the patterning activity away from the site of synthesis. Furthermore, teratogenic agents, which inhibit the synthesis of cholesterol, are an effective means of producing HPE in experimental animals such as the rat (Roux et al. 1980; Lanoue et al. 1997) . We further suspected that defects in LS would be at least as severe as those associated with SLO syndrome, which is caused by deficiency of the final step in cholesterol synthesis. This study did not provide any evidence for the LS gene in HPE pathogenesis, at least in live-born infants, which were the only samples available for analysis. Since we are aware that an incidence of HPE of 1:250 conceptuses (Matsunaga and Shiota 1977) differs from the 1:16,000 incidence at birth (Roach et al. 1975 ) by 50-fold, we cannot exclude a role for cholesterol-synthesis defects that might not be detectable in our sample of patients. Furthermore, in contrast to the SLO defect, complete loss of LS activity would severely limit sterol intermediates, suggesting that complete lack of LS activity might be lethal to the developing embryo. Although our premise was that LS defects would be recessively inherited, even modeling the mutations that we have identified as dominant is incompatible with the pedigree transmission and does not alter our conclusion that LS is not the HPE1 gene.
Analysis of the functional domains of the Sonic Hedgehog protein (Hall et al. 1995 (Hall et al. , 1997 has led us to speculate that defective cholesterol modification of the protein due to intrinsic abnormalities could be one of several mechanisms causing HPE. In addition to structural mutations in SHH-N, we are attempting to identify a category of mutations in HPE patients that could affect cholesterol transferase activity. Experiments are in progress to substantiate this hypothesis. Therefore, despite the negative results in this report, there continues to be the possibility that examination of the cholesterol synthesis pathway may yet provide additional clues to HPE pathogenesis.
